Inventiva SA (IVA)
3.07
+0.29
(+10.43%)
USD |
NASDAQ |
Jun 25, 16:00
Inventiva Enterprise Value: 161.17M for June 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 161.17M |
| June 24, 2024 | 149.92M |
| June 21, 2024 | 144.16M |
| June 20, 2024 | 156.72M |
| June 18, 2024 | 141.56M |
| June 17, 2024 | 144.16M |
| June 14, 2024 | 159.86M |
| June 13, 2024 | 169.81M |
| June 12, 2024 | 166.67M |
| June 11, 2024 | 170.08M |
| June 10, 2024 | 169.29M |
| June 07, 2024 | 189.71M |
| June 06, 2024 | 188.66M |
| June 05, 2024 | 192.85M |
| June 04, 2024 | 190.23M |
| June 03, 2024 | 200.18M |
| May 31, 2024 | 196.52M |
| May 30, 2024 | 190.77M |
| May 29, 2024 | 196.01M |
| May 28, 2024 | 189.73M |
| May 24, 2024 | 185.80M |
| May 23, 2024 | 192.01M |
| May 22, 2024 | 199.15M |
| May 21, 2024 | 203.86M |
| May 20, 2024 | 198.41M |
| Date | Value |
|---|---|
| May 17, 2024 | 203.03M |
| May 16, 2024 | 195.61M |
| May 15, 2024 | 200.20M |
| May 14, 2024 | 195.48M |
| May 13, 2024 | 190.77M |
| May 10, 2024 | 180.50M |
| May 09, 2024 | 183.11M |
| May 08, 2024 | 183.63M |
| May 07, 2024 | 184.15M |
| May 06, 2024 | 183.11M |
| May 03, 2024 | 176.33M |
| May 02, 2024 | 171.12M |
| May 01, 2024 | 173.21M |
| April 30, 2024 | 164.35M |
| April 29, 2024 | 173.21M |
| April 26, 2024 | 173.73M |
| April 25, 2024 | 169.04M |
| April 24, 2024 | 173.21M |
| April 23, 2024 | 175.81M |
| April 22, 2024 | 176.33M |
| April 19, 2024 | 177.90M |
| April 18, 2024 | 184.15M |
| April 17, 2024 | 172.16M |
| April 16, 2024 | 176.85M |
| April 15, 2024 | 175.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
38.15M
Minimum
Apr 26 2023
688.68M
Maximum
Jan 20 2021
289.26M
Average
232.16M
Median
Enterprise Value Benchmarks
| DBV Technologies SA | -8.809M |
| Cellectis SA | 88.97M |
| Genfit SA | 175.06M |
| Innate Pharma SA | 102.08M |
| Nanobiotix SA | 196.02M |
Enterprise Value Related Metrics
| Earnings Yield | -87.97% |
| Normalized Earnings Yield | -87.82 |